RFK Jr. Launches Federal Vaccine Injury Initiative: What Nurses Need to Know

Editor’s note: The author is the founder and owner of Safe Staff, a healthcare workforce safety and documentation platform. Safe Staff is a participant in the CMS Health Tech Ecosystem referenced in this article. Nurse.org received no compensation from Safe Staff for this article.

New federal initiatives could change how suspected vaccine reactions are documented, reported, and evaluated, with implications for nurses across multiple specialties.

The U.S. Department of Health and Human Services (HHS) announced a series of federal initiatives on October 8, 2026, aimed at expanding research, reporting, and clinical evaluation of suspected vaccine-related injuries.

Led by HHS Secretary Robert F. Kennedy Jr., the initiative includes a new National Institutes of Health (NIH) clinic, proposed Medicare reimbursement for clinicians, changes to electronic health record documentation, and modernization of the Vaccine Adverse Event Reporting System (VAERS).

Although several components remain in development, the announcement raises practical questions for nurses who administer vaccines, assess patients reporting adverse reactions, document medical histories, and participate in vaccine safety reporting.

Want to see more Nurse.org articles in your Google results? Add us as a preferred source.

Understanding VAERS: How the System Works Today

The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance system established in 1990 and jointly operated by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). It is a passive, early-warning system: healthcare professionals, vaccine manufacturers, patients, and the public submit reports of medical events occurring after vaccination, providers are legally required to report certain specified events, and researchers examine the resulting reports for potential safety signals that warrant further investigation through clinical review, epidemiological studies, and other surveillance systems. Because reports can be incomplete or describe conditions unrelated to vaccination, VAERS data cannot independently establish causation. A VAERS report documents what happened after vaccination, not what happened because of vaccination.

HHS outlined four major actions:

• NIH vaccine injury clinic: Opened October 5 in Bethesda, Maryland, to evaluate patients reporting health problems following vaccination and investigate potential causes.
• Medicare reimbursement: CMS is proposing payment for certain clinician activities associated with evaluating and reporting suspected vaccine-related adverse events.
• Electronic health records: HHS announced plans to require EHR systems to capture vaccine adverse-event information in a format that can follow patients across healthcare settings. The specific technical requirements have not yet been published.
• VAERS modernization: CDC is updating its reporting infrastructure to improve accessibility, including mobile reporting and tools for identifying potential safety signals.

The initiatives do not establish that every health problem reported after vaccination was caused by a vaccine. Determining causation requires additional clinical and scientific investigation.

1. Vaccine Adverse-Event Documentation Could Become More Standardized

The proposed changes to electronic health records (EHRs) may also intersect with the broader federal push toward healthcare interoperability. Through the CMS Health Tech Ecosystem initiative, federal agencies and participating technology companies have been working to improve how patient health information is exchanged across healthcare systems. The goal is to reduce fragmented medical records and make relevant clinical information more accessible to patients and providers, regardless of where care is delivered.

The newly announced vaccine adverse-event documentation initiative could build on those efforts by making suspected vaccine reactions more consistently recorded and accessible across participating EHR systems. For nurses, this could eventually mean that a suspected reaction documented in a primary care office may be available to clinicians in an emergency department or another healthcare facility. However, interoperability does not establish causation. A reported adverse event would still need to be distinguished from a medically confirmed vaccine injury. HHS has not yet clarified how these documentation requirements will integrate with the CMS Health Tech Ecosystem, whether additional nursing documentation responsibilities will be introduced, or when implementation might begin.

2. VAERS Reporting May Become Easier

Healthcare providers, including nurses, can already submit VAERS reports. Federal law requires providers to report certain adverse events, including those listed in the VAERS Table of Reportable Events Following Vaccination when they occur within specified timeframes. Providers are also encouraged to report clinically significant events even when causation is uncertain.

The CDC’s modernization effort is intended to make the reporting process more accessible, including through mobile devices. For nurses, this could eventually reduce technical barriers to submitting reports, although the effects on reporting time and nursing workload have not yet been established.

An increase in VAERS reports following the federal initiative would not, by itself, demonstrate an increase in vaccine-caused injuries. Reporting rates can also change because of public awareness, reporting incentives, or easier access to the reporting system.

3. Nurse Practitioners Could Be Affected by New Medicare Payment Policies

CMS has proposed a new Medicare billing code, GADV1, for additional time spent evaluating suspected vaccine adverse effects during qualifying outpatient encounters.

The proposal includes work performed by physicians and qualified healthcare professionals, a category that includes nurse practitioners billing independently.

Under the proposed criteria, clinicians would need to document the timing of symptoms in relation to vaccination and perform a medically appropriate assessment for alternative causes.

CMS is also proposing to add GADV1 to the Medicare Telehealth Services List, which would make the code billable for qualifying telehealth encounters beginning in 2027 if finalized.

The code remains proposed, not an established reimbursement benefit. Its eventual application to nurse practitioners will depend on the final rule, eligibility requirements, and Medicare billing policies.

The broader HHS announcement also discusses reimbursement for VAERS reporting, but nurses should not assume that submitting a report independently creates a billable service.

4. Nurses May Encounter More Questions About Vaccine Safety

The federal announcement comes amid continued public discussion about vaccine safety and immunization recommendations, and nurses frequently serve as patients’ first point of contact when questions arise about symptoms following vaccination.

The CDC’s distinction between what is reported after vaccination and what is caused by vaccination applies as directly in those patient conversations as it does in VAERS reporting itself. A health event occurring after vaccination may represent a vaccine reaction, an unrelated illness, or another medical condition requiring evaluation. Accurate clinical documentation should distinguish the patient’s reported experience, objective findings, and any medically established diagnosis.

The proposed payment structure has drawn criticism from some policy analysts, who argue that paying clinicians per report could incentivize submissions regardless of whether a plausible vaccine connection exists, potentially inflating the apparent frequency of adverse events in VAERS data. The CMS proposed rule includes documentation requirements for the code, including recording timing in relation to vaccination and assessing alternative causes. The code remains proposed.

>>Listen to The Latest Nurse News Podcast

The NIH clinic opened October 5 and is intended to combine patient evaluation with clinical research.

According to HHS, clinicians and researchers will examine health problems reported following vaccination, investigate possible causes, and explore approaches to patient care.

According to an internal NIH memo obtained by NPR, the clinic may also review the federal government’s recommended vaccine schedules as part of its research.

However, detailed eligibility criteria, referral pathways, research protocols, and the clinic’s anticipated patient capacity have not been fully established in the public announcement. The clinic does not replace existing emergency, primary care, or specialty evaluation for patients experiencing concerning symptoms.

Several components of the initiative still require additional federal action or operational guidance.

The comment period on the CY 2027 Medicare Physician Fee Schedule proposed rule closed September 14, 2026. CMS typically issues the final rule in late fall, with payment policies taking effect January 1 of the following year. Reimbursement changes are not established benefits until the final rule is published.

Healthcare organizations will need additional technical and regulatory information before implementing any new EHR requirements. CDC’s modernization of VAERS is underway, but the full impact on healthcare professionals’ reporting workflows remains to be seen.

As the federal initiatives develop, nurses and nurse practitioners may see changes in documentation systems, reporting procedures, clinical evaluation pathways, and reimbursement opportunities.

The central distinction remains the same: reporting a suspected adverse event begins an investigation. It does not establish a diagnosis or prove causation.

🤔 Nurses: how are you talking with patients about vaccine safety right now? Tell us what you think in the comments below.